|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
07.02.26 - 23:30
|
India-US trade deal: Harley, Tesla to benefit, but no risk to desi firms (Times of India)
|
|
|
US auto giants Harley Davidson, Jeep, and Tesla are poised to benefit from a new trade deal with India. The agreement offers reduced import duties on specific high-engine capacity motorcycles and cars, with concessions for Harley Davidson's 800-1,600cc bikes and a phased duty reduction for vehicles over 3,000cc, potentially boosting Tesla and Jeep's market presence without impacting domestic manufacturers....
|
|
|
|
|
|
|
|
|
|
|
07.02.26 - 21:42
|
Roche′s fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS) (GlobeNewswire EN)
|
|
|
Basel, 07 February 2026 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new late-breaking data from the Phase III FENtrepid study showing the investigational Bruton's tyrosine kinase (BTK) inhibitor fenebrutinib met its primary endpoint of non-inferiority compared to OCREVUS (ocrelizumab) in reducing disability progression in patients with primary progressive multiple sclerosis (PPMS). Fenebrutinib showed a 12% reduction in the risk of disability progression compared to OCREVUS, the only approved medicine for PPMS, as measured by the time to onset of 12-week composite confirmed disability progression (cCDP12) (hazard ratio [HR] 0.88; 95% confidence interval [CI]: 0.75, 1.03) with curves separating as early as 24 weeks. A consistent treatment effect on cCDP12 was observed across patient subgroups and for the entire treatment duration....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alle News zu Europa 6014.4445 +1.73% (E.St.50 Kurs)
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
